Erkki Elonen

Medicine · Health Sciences

44h-index7.0kcitations190works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(50), Acute Myeloid Leukemia Research(37), Chronic Lymphocytic Leukemia Research(28), Acute Lymphoblastic Leukemia research(23), Viral-associated cancers and disorders(19)

Publications190 total

Supplementary Table S1 from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Data from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Data from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Supplementary Table S3 from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Supplementary Table S3 from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Supplementary Figures, Tables and Methods from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Supplementary Figures, Tables and Methods from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Supplementary Table S2 from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Supplementary Table S2 from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Supplementary Table S1 from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
2023Open Access
Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide <scp>AML</scp>‐2003 study by the Finnish Leukemia Group
European Journal Of Haematology·2022· 2 citedOpen Access
Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia
Haematologica·2022· 2 citedOpen Access
Itraconazole Increases Ibrutinib Exposure 10‐Fold and Reduces Interindividual Variation—A Potentially Beneficial Drug‐Drug Interaction
Clinical and Translational Science·2019· 40 citedOpen Access
Sotalol, unlike the other beta‐blockers, increases the QT<sub>c</sub>interval and risk of torsades de pointes ventricular tachycardia in severe poisonings
Basic & Clinical Pharmacology & Toxicology·2019· 2 citedOpen Access
Anafylaksian aiheuttajat ja oireet
2018
Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol – a prospective nationwide study
Infectious Diseases·2017· 34 cited
A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients
Cancer Medicine·2017· 10 citedOpen Access
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
Biology of Blood and Marrow Transplantation·2016· 62 citedOpen Access
Early MRD-Negativity May Predict for Favorable Outcome Irrespective of Allotransplantation in TKI-Treated Patients with Ph-Positive Acute Lymphoblastic Leukemia
Blood·2016
Molecular Monitoring and Tailored Strategy with Pre-Emptive Rituximab Treatment for Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-up of 8.5 Years
Blood·2016· 5 cited
page 1 of 10Next →

Frequent Co-authors

Riikka Räty(11), Sakari Knuutila(10), Kaarle Franssila(10), Christian H. Geisler(8), Arne Kolstad(8), Pertti J. Neuvonen(8), Anna Laurell(7), Lone Bredo Pedersen(7), Mats Jerkeman(7), Outi Kuittinen(7), Grete F. Lauritzsen(7), Herman Nilsson‐Ehle(7), Elisabeth Ralfkiær(7), Niels Smedegaard Andersen(6), Mikael Eriksson(6), Eva Kimby(6), Mats Ehinger(6), Christer Sundström(6), Jan Delabie(6), Peter de Nully Brown(6)